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Background: The mammalian response to stress results
in the activation of stress-activated protein kinases (also
known as cJun N-terminal kinases; SAPKs or JNKs),
which are a sub-group of the mitogen-activated protein
(MAP) kinase family. The SAPKs are involved in the
upregulation of activity of the transcription factor AP-1
by post-translational modification of two of its compo-
nents, cJun and ATF2. AP-1 activity can also be elevated
by increased expression of the Fos protein, a further AP-1
component. Elk-1 (also called p62TCF), a transcription
factor involved in the induction of the expression from
the c-fos promoter through the promoter's serum
response element, is known to be activated as a result of
phosphorylation by the MAP kinases ERK1 and ERK2.
However, induction of c-fos expression in response to
noxious agents takes place in the absence of ERK activa-
tion. We therefore investigated whether SAPKs similarly
upregulate c-fos expression by phosphorylating Elk-1.
Results: Elk-1 is activated in response to stimuli other
than mitogenic signals. Both p46SAPK and p5 4 SAPK
interact physically with, and phosphorylate, Elk-1. The
capacity of Elk-1 to form a ternary complex with serum
response factor in vitro is thereby elevated. In vivo, selec-
tive activation of SAPKs stimulates formation of the
ternary complex containing Elk-1, serum response factor
and the serum response element, and enhances Elk-l-
dependent transcription. Expression of the SAPK
upstream-activator kinase, MEKKI, induces SAPK acti-
vation and c-fos transcription in the absence of ERK
activity. Phosphopeptide mapping of Elk-1 phosphory-
lated with p46sAPK or p5 4 SAPK reveals Ser383, a residue
critical for ternary complex formation and transcriptional
activation, to be the major phosphorylation site.
Conclusion: Elk-l responds to stress-induced, as well
as mitogenic, signals by stimulating c-fos transcription
through the serum response element. Phosphorylation
of Elk-I by SAPKs and the ensuing expression of
Fos protein thus constitutes an additional mechanism
by which cells can upregulate AP-I activity in response
to stress.
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Background
Upon exposure to noxious agents, cells initiate a stress-
response programme that helps them to overcome any
damage incurred to their proteins or DNA. Several of the
cellular genes that are induced in response to unfavourable
biological conditions contain AP-1 sequence elements,
and indeed, under such conditions, AP-1 transcription
factor activity is upregulated [1]. Activation of AP-1 is
known to occur by at least two distinct mechanisms.
Firstly, the amino-terminal domains of the AP-1 compo-
nents cJun and ATF2 become phosphorylated in response
to extracellular stimuli, increasing their transactivation
potential [2,3]. A second mechanism known to increase
AP-1 activity is transcriptional, for example by increased
expression of the gene encoding the AP-1 component
Fos. Growth factors cause a rapid and transient induction
of expression of the c-fos gene. This response is mediated
primarily by the ternary complex factor known as p62 TCF
or Elk-1, which is phosphorylated and activated by the
ERK1 and ERK2 mitogen-activated protein (MAP)
kinases, themselves part of a conserved signalling cascade
[4-8]. The response can be blocked by expression of
dominant-interfering mutant forms of ERK1 and ERK2,
further implicating these enzymes in the transmission of
mitogenic signals leading to c-fos induction [9].
Induced expression of c-jun and c-fos is also a response of
mammalian cells exposed to alkylating agents, the pro-
tein-synthesis inhibitor anisomycin, or ultraviolet light
[10-13]. The stress-activated protein kinases (also known
as cJun N-terminal kinases; SAPKs orJNKs) are members
of a MAP kinase sub-group capable of phosphorylating
Ser63 and Ser73 of the cJun amino-terminal domain, as
well as sites in ATF2 that are necessary for AP-1 activity
[2,14-16]. SAPKs are also implicated in the transcrip-
tional response which leads to an increase in AP-1 activity
by making Fos protein available [12]. These kinases are
strongly activated by ultraviolet light, pro-inflammatory
cytokines or anisomycin. Among these agents, ani-
somycin is reported to activate SAPKs highly selectively,
notably in the absence of ERK1 and ERK2 activation
[12]. We therefore investigated whether these enzymes
are involved in the activation of c-fos transcription.
Treatment of NIH3T3 cells with anisomycin leads to
c-fos transcriptional induction and activates endogenous
SAPKs but not ERKs. The capacity of Elk-1 to form a
ternary complex with the serum response factor (SRF)
and the serum response element (SRE) is also stimulated
by treatment of cells with anisomycin. In vitro, both
p46SAPK and p54SAPK stably interact with, and phos-
phorylate, Elk-1, leading to an increase in ternary
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complex formation. Selective stimulation of SAPKs cor-
relates with an increase in Elk-l-mediated transcription:
Elk-l-dependent reporter gene transcription is activated
in anisomycin-treated cells or in cells expressing the
SAPK upstream activator MEKK1, which, like ani-
somycin, fails to activate ERKs. Thus, phosphorylation
of Elk-1 by SAPKs leads to the induction of the c-fos
promoter in response to stress signals.
Results
The c-fos stress response correlates with SAPK activation
In resting fibroblasts, c-fos expression is undetectable, but
it is induced to maximal levels within 30 minutes of
stimulation by growth factors or phorbol esters. The
kinetics of c-fos induction in NIH3T3 cells in response
to noxious agents differ from those observed upon mito-
genic stimulation (Fig. la) [10]. The onset of transcrip-
tion after treatment of cells with 1.0 or 0.1 Vigml-l
anisomycin is delayed, as c-fos mRNA levels peak only
after 60 minutes. This observation suggests that a distinct
signalling pathway may be involved.
Superinduction of 'immediate-early' gene transcription
in response to inhibition of protein synthesis is a well-
documented phenomenon [17]. However, the induction
of immediate-early gene expression by anisomycin has
been documented to occur independently of protein
synthesis inhibition [11,18]. Several observations confirm
that the induction of c-fos expression by anisomycin
under our experimental conditions occurs in the absence
of translational inhibition. If c-fos induction resulted from
inhibition of protein synthesis, one would expect the
induction to be enhanced with increasing concentrations
of anisomycin. However, the same delayed kinetics are
Fig. 1. (a) Kinetics of c-fos induction. Northern hybridization
analysis of c-fos expression in response to treatment of NIH3T3
cells with 15 % serum, 100 pIg ml-1' TPA (top), or 1 pLg ml-1 or
100 ng ml-1 anisomycin (A 1 000 and A 100, lower panels). The
times after treatment at which RNA was isolated are given in
minutes. Cells were serum-starved for 24 h prior to treatment.
RNA was isolated and analyzed as described [5]. (b) Activation
of ERKs by phorbol ester (TPA) but not anisomycin. Untrans-
fected NIH3T3 cells (left panels) or cells over-expressing
haemagglutinin-tagged (HA-) ERK1 (middle) or ERK2 (right) were
serum-starved (-) or starved and treated with 100 ng ml-' TPA (T)
or 100 ng ml-1 anisomycin (A). Cell lysates were tested for
myelin basic protein (MBP) kinase activity, either directly, by in-
gel kinase assays (middle panels), or by preparing immune com-
plexes, which were assayed in solution (lower panels). The
haemagglutinin-tagged ERKs migrate more slowly than endo-
genous ERKs, as indicated. The top panels are immunoblots
using a mouse monoclonal anti-haemagglutinin antibody
12CA5. (c) Activation of SAPKs by anisomycin but not TPA.
NIH3T3 cells were starved and treated with nothing (-) or
100 ng ml-1 anisomycin (A 100), 1 Ig mi- 1 anisomycin (A 1 000)
or 100 ng ml-1 TPA (T), as indicated, and lysates were either loaded directly onto a polyacrylamide gel co-polymerized with GST-EIkC
fusion protein (left), or immunoprecipitated with an antiserum against SAPKs prior to SDS-PAGE (middle panel). The position of a con-
stitutive kinase activity that is independent of co-polymerized substrate is denoted by an asterisk. The positions of the endogenous
p46SAPK and p54 sAPK are indicated by arrows in the middle panel. NIH3T3 cells over-expressing haemagglutinin-tagged p46 sAPK(HA-SAPK; right panel) were treated as above or with 10 % FCS (S). Cell lysates were prepared and p46SAPK activity was tested in
immune-complex kinase assays with GST-cJun fusion protein.
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observed with anisomycin concentrations ranging from
1 Lg ml-1 to 50 ng ml- . Furthermore, 1 g ml- ani-
somycin induces the de novo production of Fos protein to
levels comparable to those induced by 12-O-tetrade-
canoylphorbol-13-acetate (TPA; data not shown). It also
stimulates the expression of chloramphenicol acetyl-
transferase (CAT) from reporter constructs (see below)
and fails to reduce -galactosidase expression from a co-
transfected gene. Therefore, in agreement with published
data [11,12,18], we conclude that the observed induction
of c-fos expression by anisomycin occurs independently
of protein synthesis inhibition. The transcriptional
response observed one hour after anisomycin treatment is
comparable to the TPA response that is already apparent
after 24 minutes (Fig. la). However, neither TPA nor
anisomycin is as potent as serum, which exerts its effects
through multiple pathways.
In order to determine which MAP kinases are activated
in response to stress signals, we examined their activity in
serum-starved NIH3T3 cells treated with either TPA or
anisomycin. As expected, the activation of endogenous
ERKs in response to TPA could be detected in cell
lysates by an in-gel kinase assay (Fig. lb, middle panels,
lanes marked T). In contrast, endogenous ERKs were
not activated by anisomycin (Fig. lb, middle panels, lanes
marked A). The activation of endogenous SAPKs was
analyzed in a similar manner. NIH3T3 cells were treated
with TPA or anisomycin and cell lysates were analyzed
using as a substrate a fusion protein made up of glu-
tathione-S-transferase and an amino-terminally truncated
Elk-1 protein (GST-ElkC; Fig. c). The two SAPK iso-
forms are 46 and 54 kDa. A 46 kDa kinase activity was
induced in response to anisomycin but not in response to
TPA. The presence of a constitutive activity, which was
independent of substrate (data not shown), precluded
analysis in the 52-56kD range (Fig. 1c, left panel).
Therefore, in order to confirm the identity of the 46 kDa
activity and to determine whether p54SAPK is also acti-
vated, endogenous SAPKs were immunoprecipitated
from the lysates and analyzed in parallel (Fig. 1c, middle
panel). The 46 kDa kinase could thus be identified as
p4 6 SAPK, and in the absence of background phosphoryla-
tion, the activation of p54SAPK by anisomycin treatment
was also apparent. Thus, although we cannot exclude the
existence of additional, anisomycin-induced Elk-1
kinases that do not renature under these experimental
conditions or are obscured by the presence of constitutive
activities, p4 6 SAPK and p54SAPK are clearly detected as
endogenous Elk-1 kinases that are activated upon
treatment of NIH3T3 cells with anisomycin.
Regulation of epitope-tagged kinases was also investi-
gated under these conditions. NIH3T3 cells were trans-
fected with vectors for haemagglutinin-tagged ERKs and
SAPKs and their expression was confirmed by western
immunoblot analyses (Fig. lb and data not shown). Cells
were serum-starved and treated with either TPA or
anisomycin. The in-gel kinase assays with whole cell
lysates (Fig. lb, middle panels) show that the activity of
epitope-tagged ERK1 is stimulated by TPA but not
by anisomycin, as is its endogenous counterpart. In
addition, immune-complex kinase assays (Fig. lb, lower
panels) revealed the stimulation of both epitope-tagged
ERK1 and epitope-tagged ERK2 by TPA but not
by anisomycin.
The enzyme activity in lysates of cells transfected with
haemagglutinin-tagged p46SAPK was also assayed in an
immune-complex kinase assay. Anisomycin at 1.0 and
0.1 gm l- 1 strongly activated p46SAPK, whereas TPA
and serum were ineffective (Fig. c, right panel). Thus,
the activation pattern of the transfected SAPKs and
ERKs faithfully reflects that of the endogenous MAP
kinases. The observation that TPA and anisomycin acti-
vate distinct MAP kinase sub-groups without detectable
overlap further implies that the anisomycin-induced c-fos
expression in NIH3T3 cells is mediated by a signalling
pathway distinct from the one used by TPA.
Induction of c-fos by stress signals is mediated by Elk-1
acting through the SRE
The induction of c-fos expression in response to TPA is
mediated by the SRE [19,20]. Two factors, SRF and
Elk-1, bind to the SRE as a ternary complex. Phosphory-
lation of Elk-1 by ERKs is known to stimulate ternary
complex formation [5,8]. Transfection of NIH3T3 cells
with an SRE-CAT reporter gene construct and subse-
quent treatment with TPA or anisomycin revealed that the
SRE responds similarly to both reagents (data not shown).
In order to test whether anisomycin leads to stimulation
of ternary complex formation by Elk-1, lysates were pre-
pared from either NIH3T3 cells over-expressing Elk-1
that had been serum-starved, or such cells subsequently
treated with either serum, anisomycin or TPA for
30 minutes. Analysis of ternary complex activity in the
lysates by mobility-shift assays with the SRE and a trun-
cated variant of SRF (coreSRF) confirmed that all three
agents stimulate the formation of a ternary complex by
Elk-1 (Fig. 2, lanes 5, 7 and 9). Addition of a polyclonal
antiserum raised against Elk-1 disrupted the complex
formed (Fig. 2, lanes 6, 8 and 10), thus confirming its
identity. These results show that ternary complex forma-
tion by Elk-1 is stimulated in cells under conditions that
activate SAPKs but not ERKs, implying that SAPKs
phosphorylate and activate Elk-1 in intact cells in
response to stress signals. Comparable amounts of ternary
complex activity are induced by TPA and anisomycin,
although neither of these is as potent as serum. Indeed,
the levels of ternary complex formation induced by these
agonists correlate with the induced strength of c-fos
mRNA expression observed in Figure la.
SAPKs directly phosphorylate and activate Elk-1
We wanted to assess whether the activation of Elk-1
observed in vivo under conditions that activate SAPKs is
the result of direct phosphorylation by SAPKs. To this
end, epitope-tagged p46SAPK and p54SAPK were over-
expressed in COS cells and their ability to phosphorylate
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Bacterially expressed Elk-1, phosphorylated with either
p46SAPK or p54SAPK, was analyzed for its ability to form
ternary complexes with the SRE and coreSR F. Figure 3b
shows that activated SAPKs isolated from cells stimulate
the formation of a ternary complex by Elk-1 (Fig. 3b,
lanes 8 and 10). Again, addition of a polyclonal antiserum
raised against Elk-1 disrupted the complex formed after
p4 6SAPK treatment of Elk-1 (Fig. 3b, lane 12). The addi-
tional bands seen in lanes 6-10 of Figure 3b, below the
ternary complex, reflect complexes formed by truncated
forms of bacterially expressed Elk-1. The inducible
ternary complex activity that is observed upon anisomycin
stimulation of cells can therefore be reproduced by phos-
phorylating recombinant Elk-1 with SAPKs in vitro. The
observation that Elk-1 is phosphorylated directly and acti-
vated by p46s APK and p54SAPK further implicates it in the
stress-response induction of the c-fos gene.
Fig. 2. Anisomycin stimulates ternary complex formation by
Elk-1. Untransfected NIH3T3 cells or cells over-expressing Elk-1
were serum-starved or starved and treated with 15 % FCS
(serum), 100 ng ml-1 TPA or 1000 ng ml-' anisomycin (anis.) as
indicated. After 30 min, lysates were prepared and tested for
ternary complex activity by mobility shift assays with an SRE
probe and coreRF. The ternary complex with coreSRF and Elk- is
indicated as cll. The identity of the complexes was confirmed by
including a polyclonal antibody against Elk-1 in the binding
reactions (lanes 6,8,10).
Elk-1 was tested in immune-complex kinase assays. As
shown in Figure 3a, Elk-1 is phosphorylated by both
kinases, each of which is strongly stimulated by pre-treat-
ment of cells with ultraviolet light. This is consistent
with the observation that GST-ElkC fusion protein is
phosphorylated by the endogenous SAPKs present in
NIH3T3 cells (Fig. c).
Determination of SAPK phosphorylation sites in Elk-1
SAPKs are proline-directed serine/threonine kinases, as
are their ERK relatives. However, except for sites in the
amino-terminal transactivation domains of cJun [2] and
ATF2 [15,21,22], little is known of their potential sub-
strates. We have previously undertaken a comprehensive
phosphopeptide mapping analysis of Elk-1 proteins that
have been mutated at individual phosphorylation sites and
phosphorylated by ERK1 [8]. On the basis of this infor-
mation, which is summarized in schematic form in Figure
4e, we sought to determine whether p4 6s APK or p54SAPK
phosphorylates known sites in the regulatory domain of
Elk-1. An amino-terminally truncated form of Elk-1
(ElkC) was radiolabelled by incubation with y-[32 P]ATP
and p46SAP K or p54SAPK. For comparison, ElkC was also
phosphorylated using recombinant ERK1 that had been
activated by phosphorylation with a constitutively active
mutant of the MAPK/ERK kinase MKK1 [23]. Figure 4
displays the phosphopeptide maps generated after
phosphorylation of ElkC by the three kinases.
The phosphopeptide pattern generated after phosphory-
lation of ElkC with recombinant ERK1 (expressed in
bacteria) is identical to that obtained with a homo-
geneous preparation of ERK1 from Ratl cells [8]. This
demonstrates that activated ERK1 generated from
recombinant, purified components exhibits identical
Fig. 3. Phosphorylation and activation
of Elk-l by SAPKs. (a) Mock-immune
complexes or complexes containing
either inactive or activated (+UV)
p46 sAPK or p54 APK were incubated with
bacterially expressed Elk-1 (bElk-1) or
without further addition. Reaction prod-
ucts were separated on 10 % SDS-poly-
acrylamide gels. (b) Gel-retardation
analysis of Elk-1 after phosphorylation
with active or UV-activated p46 sAPK or
p54 SAPK (or nothing, -) as indicated. The
identity of the ternary complex was con-
firmed by including a polyclonal anti-
body against Elk-l in the binding
reaction (lane 12).
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Fig. 4. Phosphopeptide analysis of
amino-terminally truncated Elk-i (ElkC)
phosphorylated by ERK1 or SAPKs. Top
row: EIkC phosphorylated with either
(a) p46SAPK, (b) ERK1, or (c) p54SAPK.
Bottom row: ElkC phosphorylated with
either (d) p46SAPK or (f) p54SAPK, mixed
with ERK-phosphorylated ElkC; and (e)
a schematic representation of the previ-
ously identified peptides generated from
ERK1-phosphorylated ElkC [8].
substrate specificity to the endogenous enzyme. The sub-
strate specificities of p46SAPK and p54 SAPK are more
restricted than that of ERK1, as fewer ElkC phospho-
peptides are recovered after phosphorylation with these
enzymes. The major phosphopeptide detected with
p4 6sAPK and with p54SAPK is similar in mobility to a
major phosphopeptide in the ERK1 map (Fig. 4b). This
peptide was previously demonstrated to contain phospho-
serine at position 383 [8]. An additional phosphopeptide
is generated by incubation of ElkC with p4 6sAPK.
To confirm the identity of these peptides, mixing
experiments were performed with ElkC phosphorylated
by ERK1 and p46 sAPK or p54SAPK (Fig. 4d,f). The
major peptides derived from ElkC phosphorylated with
p4 6SAPK and p54SAPK comigrate with a major phospho-
serine 383-containing peptide from ERK1-phosphory-
lated ElkC, demonstrating that these are identical
peptides. The additional peptide obtained with p4 6sAPK
comigrates with a peptide containing Ser324, which is
less strongly phosphorylated by ERK1 in vitro. Ternary
complex formation by Elk-1 is increased after treatment
with either of the SAPKs, suggesting that phosphoryla-
tion of Ser324 is not a prerequisite for ternary complex
formation in vitro. This is entirely consistent with our
previous observations [8].
Fig. 5. SAPKs form complexes with Elk-1. (a) Lysates from COS cells transfected and treated as indicated were first pre-cleared with GST
bound to glutathione-agarose beads. Subsequently, 6.5 Lg of GST-cJun or GST-EIkC bound to beads were incubated in aliquots of the
lysates. Beads were washed as described for the immunoprecipitations and resuspended in kinase buffer containing 5 .Ci -[32P]ATP.
After 1 h, reactions were stopped and subjected to SDS-PAGE. Phosphorylation of GST-cJun or GST-EIkC was dependent on ultraviolet
treatment of the cells (lanes 5-7 and 11-13). (b) As for (a), except that complexes were denatured directly and subjected to western
immunoblot analysis with a monoclonal antibody directed against the haemagglutinin tag.
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SAPKs form complexes with Elk-1 in vitro
The SAPKs have been shown to form stable complexes
with their substrates cJun and ATF2 in vitro
[2,15,21,22,24]. We therefore investigated whether
SAPKs interact physically with Elk-1. Lysates from
untransfected COS cells, or from cells transfected with
epitope-tagged p46 sAPK or p54SAPK, were incubated
with fusion proteins made up of either GST and cJun
(residues 1-223) or GST and ElkC (residues 215-428 of
Elk-1) pre-bound to glutathione-agarose beads. The
beads were washed extensively, resuspended in kinase
buffer and assayed for the presence of kinase activity. As
seen in Figure 5a, both cJun and ElkC were phosphory-
lated after pre-incubation in lysates of cells treated with
ultraviolet light but not in lysates of untreated cells. This
is consistent with stress-inducible kinases that are present
in the lysates of untransfected (Fig. 5a, lanes 5 and 11)
and transfected (Fig. 5a, lanes 6, 7, 12 and 13) cells
binding to GST-cJun and GST-ElkC.
To confirm that p46sAPK and p54SAPK had complexed
with cJun and ElkC, GST-cJun and GST-ElkC beads
were collected after incubation with the lysates, washed
extensively and bound proteins were subjected to western
immunoblot analysis with a monoclonal antibody direc-
ted against the epitope tag. Figure 5b shows that the
p46 sAPK and p54SAPK present in lysates of both unin-
duced and induced cells bound with comparable effi-
ciency to cJun and ElkC. The binding of inactive SAPKs
to cJun has been observed previously in U937 cells and
appears to be a constitutive property of these enzymes
[25]. Thus, as with other known substrates, SAPKs form
complexes with Elk-1.
Elk-1 mediates transcriptional activation in response to
stress signals
Phosphorylation by ERKs is known to stimulate the
transactivation potential of Elk-1. To probe the involve-
ment of Elk-1 in the transcriptional response of c-fos to
stress signals, we used chimeric Gal-Elk fusion proteins.
These have previously been shown to mediate the
stimulation of GAL4 reporter gene expression by
mitogenic stimuli [6,8,9]. In NIH3T3 cells, co-transfec-
tion of an expression vector for Gal-Elk mediates expres-
sion from a transfected GAL-CAT reporter gene, which,
as shown in Figure 6a,b, is potentiated upon treatment of
serum-starved cells with anisomycin. Replacement of the
major SAPK phosphorylation site in Gal-Elk, Ser383,
Fig. 6. (a) Activation of Gal-Elk-dependent gene expression by anisomycin. Cells were transfected with a Gal-Elk chimeric protein and
treated with anisomycin as indicated. (b) Quantification of three experiments similar to the one shown in (a). Values are given as per-
centage CAT conversion relative to untreated cells expressing Gal-Elk; error bars give the standard deviation. (c) Activation of Gal-Elk-
dependent transcription by MEKK1. The transfected amounts of MEKK1 expression vector are shown. (d) Quantification (as in b) of
three experiments similar to the one shown in (b). Values are given as percentage CAT conversion relative to cells expressing Gal-Elk
alone. (e) Selective activation of SAPKs by MEKK expression. Over-expression of epitope-tagged (HA-) ERK1 and ERK2 was monitored
by western immunoblot analysis with a polyclonal anti-ERK antibody and MBP kinase activity by immune complex kinase assays
(upper panels); over-expression of epitope-tagged p46 SAPK and p545APK was monitored by western immunoblot analysis with a poly-
clonal anti-SAPK antibody and GST-cJun kinase activity by immune complex kinase assays (lower panels). The haemagglutinin-tagged
kinases migrate more slowly than their endogenous counterparts.
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with alanine (Gal-Elks 3 83A) abrogates induction of repor-
ter gene expression. In contrast, when Ser383 is replaced
with glutamate (Gal-Elks 3 83E) Gal-Elk retains 60 % of its
activation potential, in agreement with previous analyses
of Elk-1 activation by ERKs. These results show that
phosphorylation at Ser383 is a prerequisite for transcrip-
tional activation by Elk-1 in response to treatment of
cells with anisomycin.
SAPK activation is a consequence of phosphorylation by
upstream activators like SEK1, which in turn is activated
by MEKK1 [26,27]. As a further test for the activation of
Gal-Elk by SAPKs, cells were co-transfected with
expression vectors encoding MEKK1 [28] Gal-Elk and
the GAL-CAT reporter construct. Co-transfection of
1.25 j-g MEKK1 expression vector elicited a 24-fold
activation of Gal-Elk-dependent reporter expression in
serum-starved NIH3T3 cells (Fig. 6c,d). The stepwise
reduction of MEKK1 expression vector input to 2.5 ng
led to the gradual loss of detectable reporter activity.
To confirm that MEKK1 expression selectively activates
SAPKs and not ERKs under these conditions, epitope-
tagged ERKs and SAPKs were over-expressed together
with MEKK1 in serum-starved NIH3T3 cells, and their
activities were assayed in immune-complex kinase assays,
as before. As shown in Figure 6e, expression of MEKK1
fails to activate either ERK1 or ERK2, whereas both
p46 SAPK and p54SAPK are activated at expression levels
that result in reporter gene expression. This result indi-
cates that, at the levels of expression achieved, MEKK1
selectively activates SAPKs and that this is sufficient to
induce Gal-Elk-dependent gene expression.
Discussion
Transcription of c-fos induced by mitogens or stress results
from activation of distinct MAP kinase sub-groups
Several biological agonists, such as ultraviolet light, pro-
inflammatory cytokines and anisomycin have been
reported to stimulate the SAPK sub-group of MAP
kinases with varying degrees of specificity. In order to
study the relationship of SAPKs to the induction of c-fos
transcription, we chose to use anisomycin because it
allows a clear distinction to be made between mitogen-
induced and stress-induced pathways. At concentrations
that do not affect protein synthesis, anisomycin stimulates
the activity of endogenous SAPKs and induces c-fos tran-
scription in NIH3T3 cells without concomitant ERK
activation. The level of c-fos induction achieved by ani-
somycin treatment is comparable to the response of cells
to treatment with TPA. However, the latter is mediated
by the stimulation of ERKs without detectable SAPK
activation. The induction of c-fos expression resulting
from exposure of cells to noxious agents can be distin-
guished from the induction in response to mitogens by its
delayed kinetics. The observed time course of c-fos
induction by anisomycin may thus reflect the prolonged
activation kinetics exhibited by SAPKs (our unpublished
observations). We also observe that the selective acti-
vation of endogenous SAPKs and ERKs by anisomycin
and TPA, respectively, is faithfully reproduced by exoge-
nously expressed, epitope-tagged versions of the kinases.
Elk-1 activation as a result of phosphorylation by SAPK
Efficient formation of a ternary complex between Elk-l,
SRF and the c-fos SRE requires phosphorylation of Elk-
1 on regulatory sites in its carboxy-terminal domain. We
observe that ternary complex formation by Elk-1 is
induced in serum-starved NIH3T3 cells treated with ani-
somycin. The level of ternary complex formation is
comparable to that induced by TPA. However, whereas
TPA stimulates ERKs selectively, anisomycin was found
to stimulate only SAPKs. This result strongly suggests
that SAPKs phosphorylate Elk-1 in vivo. Consistent with
this is the observation that Elk-1 is phosphorylated
directly by SAPKs in vitro, whereupon its ability to form
a ternary complex with SRF is enhanced. Although we
have observed that the ternary complex factor Sapla is
also phosphorylated by SAPKs in vitro, this does not
appear to stimulate its capacity to form a ternary com-
plex with SRF (our unpublished observations).
Phosphopeptide mapping shows that SAPKs phosphory-
late Elk-1 predominantly at Ser383, the major carboxy-
terminal site in Elk-1 phosphorylated in intact cells in re-
sponse to serum, EGF, and expression of oncogenic forms
of Raf-1 kinase [6,8,9,29]. Phosphorylation of Elk-1 by
SAPKs therefore occurs at a physiologically relevant site.
However, at least one other site in Elk-1 - Ser324 - is
phosphorylated with similar efficiency by p46sAPK, which
appears to be the major anisomycin-induced SAPK in
NIH3T3 cells. Comparison of SAPK phosphorylation
sites in cJun, ATF2 and Elk-1 shows that the SAPKs may
have a less stringent requirement for a basic residue before
the phosphorylated residue than do the ERKs [30].
Otherwise, the sequences are remarkably similar. The
specificity determinant may therefore be in the substrate
domain that mediates interaction with the SAPKs.
SAPK interactions with Elk-1
As seen with other SAPK substrates such as cJun, Elk-i
forms stable complexes with both inactive and active
forms of the stress-inducible kinases, including epitope-
tagged p46SAPK and p54SAPK. The interaction of SAPKs
with Elk-1 was demonstrated in two ways. Firstly, the
kinases were found to remain complexed through several
washes to immobilized GST-ElkC, and subsequently to
phosphorylate the substrate to which they had bound.
Secondly, the presence of SAPKs in complexes with
GST-ElkC was confirmed by immunoreactivity. This
approach revealed the interaction of inactive SAPKs with
Elk-1. Inactive SAPKs have been reported previously to
interact with their substrate cJun, implicating them in a
mechanism of AP-1 repression in resting cells [25].
Although our data implicate SAPKs in phosphorylation
of Elk-1 in response to stress signals, we cannot rule
out the possibility that anisomycin-induced kinases other
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Fig. 7. Regulation of AP-1 activity by
multiple mechanisms. Mitogenic sig-
nals lead to activation of the ERKs and
phosphorylation of Elk-l, which results
in induction of c-fos expression [5,6].
Alternatively, biological stress leads to
the upregulation of AP-1 activity by
several mechanism. SAPKs phosphory-
late ATF2, resulting in increased
expression of c-jun [211. Phosphoryla-
tion of Elk-1 by SAPKs results in an
increase in ternary complex activity,
leading to an induction of c-fos expres-
sion. As the level of Fos in resting cells
is extremely low, induction of its
expression shifts the balance from cJun
homodimers to Fos-cJun heterodimers,
because cun preferentially forms het-
erodimers with Fos. SAPKs also directly
phosphorylate cjun, thereby increasing
its transcriptional activity (see [3] and
references therein).
than SAPKs may be involved in Elk-1 regulation. In this
respect, a novel sub-group of mammalian MAP kinases
was identified recently, whose members, exemplified by
p38, are homologues of the yeast HOG1 kinase and can
be activated by osmotic stress and arsenite treatment of
mammalian cells [31,32]. This sub-group of MAP kinases
appears to share some substrates with the SAPKs [33].
Although our in-gel kinase assays, performed with lysates
from untransfected anisomycin-treated cells indicate that
SAPKs are the major anisomycin-activated GST-ElkC
kinases in NIH3T3 cells, we cannot rule out the possibil-
ity that other MAP kinases, such as p38/HOG1, may
contribute to Elk-1 phosphorylation under some cir-
cumstances. The existence of other mammalian MAP
kinases and the possibility that they activate Elk-1 in
response to distinct stimuli is of great interest and will be
the subject of future studies. Here, we have shown that,
in addition to ERKs, members of a second group of
MAP kinases, p4 6sAPK and p5 4 SAPK, phosphorylate and
activate Elk-1.
Transcriptional regulation of Elk-i by SAPKs
Although the phosphorylation of Ser383 is a prerequisite
for Elk-1 function, the mutation of other potential
phosphorylation sites in Elk-1 to alanine also impairs
transcriptional activation [6-8], suggesting that phos-
phorylation of Ser383 alone is not sufficient for full tran-
scriptional activation. Mutation of Ser383 to alanine in
Gal-Elk abolishes the ability of the fusion protein to
respond to mitogenic stimuli [6,8,9] and anisomycin (Fig.
6) in a GAL4 reporter assay, whereas the introduction of a
negative charge at residue 383 (Gal-Elks 38 3E) allows 60 %
activation compared to native Gal-Elk. However, expres-
sion of this construct does not lead to constitutive activa-
tion in the absence of a stimulus [8,9]. This also implies
that other phosphorylation sites contribute to the full
activity of Elk-1. In the case of anisomycin stimulation of
NIH3T3 cells, p4 6sAPK is the predominant endogenous
SAPK. This enzyme phosphorylates Ser324 in addition to
Ser383 (Fig. 4). Therefore, Ser324 phosphorylation may
contribute to the anisomycin-induced activation of Elk-1.
Activation of SAPKs is thought to occur upon sequential
activation of MEKK1 and SEK1, which then phosphory-
lates the SAPKs [27,34]. Consistent with this model, the
transient expression of MEKK1 in NIH3T3 cells led to
high levels of transcription from the Gal-Elk-dependent
reporter. However, overexpression of MEKK1 has been
shown to activate both SAPKs and ERKs indiscrimi-
nately in some instances. Therefore it was important to
monitor the activation of ERKs and SAPKs at various
levels of MEKK1 expression under our experimental
conditions. In contrast to published observations, we
found that expression of MEKK1 failed to activate ERKs
but did activate SAPKs and stimulated Gal-Elk-depen-
dent transcription. We have only been able to detect the
stimulation of ERKs by over-expressing a MEKK1
derivative consisting exclusively of the catalytic domain
(our unpublished observations).
AP-1 regulation in response to biological stress
AP-1 activity is subject to upregulation in response to
SAPK activation at several levels (Fig. 7). The SAPKs are
implicated in the elevation of AP-1 activity through phos-
phorylation of two amino-terminal sites in cJun; they also
form complexes with, and phosphorylate, ATF2, a com-
ponent of AP-1 which is involved in the upregulation of
c-jun transcription. Here, we have identified a third sub-
strate of SAPKs, highlighting an additional mechanism of
AP-1 upregulation in response to stress-induced signals. By
phosphorylating and activating Elk-1, which acts through
the SRE to activate c-fos transcription, SAPKs induce the
production of Fos, a further component of AP-1.
The influence of phosphorylation on the DNA binding
properties of Elk-1 is reminiscent of the regulation of
Elk-1 activation by stress-activated protein kinases Gille et al.
ATF2 DNA-binding and transcriptional activation by
ERK2 and p54SAPK [15,35]. Thus, the production of
two AP-1 components, cJun and Fos, is induced in
response to stress signals. The increased availability of Fos
protein is thought to shift the balance from cJun homo-
dimers to Jun-Fos heterodimers, thereby changing the
pattern of AP-l-dependent gene expression [36].
Conclusion
Activation of SAPKs involves a kinase cascade distinct
from the signalling pathway involving Raf-1 kinase,
MEKs and ERKs. In response to biological stress,
MEKK1 and SEK1 appear to act sequentially to activate
p46 SAPK and p5 4 SAPK [27], which then phosphorylate
and activate cJun, ATF2 and Elk-1. AP-1 thus constitutes
an integration point for multiple targets activated by cel-
lular stress. Our results identify Elk-1 as a target for the
pathway leading to induction of c-fos gene expression in
response to biological stress. We conclude that both the
mitogenic and the stress signalling pathways converge on
a single ternary complex factor, Elk-1, at the c-fos SRE.
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Materials and methods
Cell culture and transfections
NIH3T3 and COS cells were grown in DMEM supplemented
with 10 % FCS. Cells were transfected with DNA-calcium
phosphate co-precipitates according to standard procedures.
For CAT reporter analysis, cells were routinely starved for 20 h
before treatment with anisomycin (1 tLg ml- i) and harvested
8 h later. Transfection efficiency was monitored by -galac-
tosidase activity in extracts expressed from co-transfected
pCM110 (Pharmacia). CAT assays were performed as
described [9]. Expression of Gal-Elk was monitored by west-
ern analysis with monoclonal antibodies against Gal4 (amino
acids 1-147) [9]. For over-expression and isolation of epitope-
tagged SAPKs and ERKs in NIH3T3 cells, 5 g haemagglu-
tinin-tagged p46SAPK and p54 SAPK constructs [26] or 6 g
haemagglutinin-tagged ERK1 and ERK2 constructs were
transfected. Cells were treated with serum, TPA or anisomycin
as described in the figure legends. After 10 min (ERKs) or
30 min (SAPKs), cells were harvested.
Gel-retardation analysis
For mobility-shift analysis of Elk-1 ternary complex activity,
lysates were prepared as described [8] from serum-starved cells
or cells treated with serum, TPA or anisomycin as indicated in
the Figure 2 legend. Elk-1 expression was monitored by west-
ern immunoblot analysis. Equal amounts of each extract were
used for gel-retardation analysis with coreSRF and an SRE
oligonucleotide probe as described [8]. Polyclonal antibody
(0.5 pI1) specific for Elk-1 was added to DNA-binding reac-
tions where indicated.
Immune-complex kinase assays
Cells were washed in ice cold PBS and lysed in RIPA buffer
[37]. Lysates were clarified by centrifugation at 4 °C. Pre-
swollen protein A-Sepharose was incubated 30 min in PBS
with I % BSA to block non-specific protein binding. Beads
were washed three times with WPTX (0.05 % Triton X-100,
50 mM Tris-HCI pH 8.0, 150 mM NaCl, 1 mM CaC1 2,
1 mgml 1- ovalbumin), and coupled to mouse monoclonal
anti-haemagglutinin antibody (12CA5; Boehringer) by incuba-
tion in WPTX for 1 h. The beads were washed three times in
the same buffer and aliquots were added to the lysates. Mock
precipitations were performed with lysates from cells trans-
fected with pUC8. Immunoprecipitations were carried out at
4 °C for 2-3 h. The beads were washed twice in WPTX, once
in WPTX with 400 mM NaCl and again in WPTX. The final
wash was carried out in ERK buffer (25 mM Tris-HC pH
7.2, 10 mM MgCl 2, 1 mM DTT, 0.1 mM EGTA, 20 mM
p-nitrophenylphosphate) or SAPK buffer ( 20 mM HEPES pH
7.9, 20 mM MgCl2, 10 mM 2-glycerophosphate, 0.5 mM
Na3VO 4, 10 mM p-nitrophenylphosphate and 2 mM DTT).
The beads were used directly for kinase assays with MBP
(ERKs) or GST-cJun (SAPKs) in the presence of 5 Ci
'y-[32P]ATP and 40 p.M ATP. Reactions were terminated after
one hour at 37 C by addition of SDS sample buffer.
To obtain highly active SAPKs, COS cells were transfected
with 8 g haemagglutinin-tagged p46pSAPK and p543SAPK
constructs [26]; 24 h after transfection, cells were transferred to
0.5 % serum for 10-12 h. Cells were subjected to 254 nm UV
radiation for 15 s, then the medium was returned to the cells.
After 30 min, cells were lysed and SAPKs were immunopre-
cipitated as above. The protein A beads were used for kinase
assays as described above. For subsequent gel-retardation
analysis, kinase reactions were set up in SAPK buffer, contain-
ing 250 p.M ATP. Reactions contained -200 ng ternary com-
plex factor Elk-1 or no further protein and were carried out
for 1 h at 37 C. Aliquots of the reactions were used for gel-
retardation analysis.
In-gel kinase assays
ERK activity was assayed after renaturation in polyacrylamide
gels as described [9]. Gels for SAPK assays contained
-10 Fg ml- l GST-ElkC and 0.2 Lg ml- l polyGlu-Tyr, which
serves to suppress some of the nonspecific bands that are
also present when gels were cast without the GST-ElkC
substrate [12].
Phosphopeptide mapping
Kinase reactions contained 1 pg ElkC (carboxy-terminal
amino acids 213-428), 20 p.M ATP and 80-100 Ci
y-[32P]ATP. The ElkC protein was repurified by SDS-poly-
acrylamide electrophoresis and cleaved in solution with a 10:1
mixture of trypsin and chymotrypsin following a previously
established protocol to allow comparison with the two-dimen-
sional phosphopeptide maps obtained with various mutants of
Elk-1 [8]. For direct comparison, phosphopeptide maps from
ERK1-phosphorylated ElkC were generated in parallel. R4F is
a constitutively active mutant of MAP kinase kinase 1
(MKK1), which contains negatively charged residues at both
activating phosphorylation sites and an internal amino-terminal
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deletion [23]. ERK1 (400 ng) was activated by incubation with
24 ng R4F.MKK1 in 50 I.ul reactions containing 25 mM
Tris-HCl pH 7.2, 10 mM MgC1 2, 500 nM okadaic acid,
5 mM p-nitrophenylphosphate, 1 mM DTT, 0.1 mM EGTA,
250 F.M ATP for one hour at 37 °C. Mock reactions lacking
ERKI were also performed. Subsequently, 5-10 I.l recombi-
nant kinases were used to phosphorylate ElkC in the presence
of 50.Ci y-[ 32P]ATP without further ATP addition. No
incorporation of radioactivity into ElkC was observed with
R4F.MKKI from the mock activation reactions.
DNA constructs
Expression vectors for haemagglutinin-tagged SAPKs [38] and
for haemagglutinin-tagged ERKs [39] have been described. A
MEKK cDNA was cloned from mouse spleen total cDNA by
PCR and sequenced. The pCMV5-based eukaryotic vector
[40] derived from the cDNA clone expresses a MEKK protein
encoded by nucleotides 477-2500 of the published sequence
[28] with a heptapeptide leader and a carboxy-terminal histi-
dine tag.
The bacterial expression vectors for Elk-1 and ElkC
(pQE.Elk-1 and pQE.ElkC) have been described [8], as has the
vector for GST-Jun(1-223) [41]. The eukaryotic expression
vectors for Elk-1, Gal-Elk, Gal-Elks38 3A and Gal-ElkS383E
(pCMV5.Elk-1, pSG.GalElk/383A/383E) and the reporter
plasmid GAL-CAT have also been described previously [8,9].
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